Daily Judi

Daily Judi: Monday, March 20, 2023

Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:

Anthony King reports on Pfizer's agreement to buy Seagen for $43 billion. Seagen, based in Washington State, makes antibody drug conjugates that deliver highly potent chemotherapy agents to kill cancer cells. (Chemistry World)

Considering breakthrough data science, machine learning, and AI, Jacob Skinner and Will Berriss of Thrive Wearables discuss the evolving medical devices landscape. (Med Device Online)

In an advice column for the Washington Post, Mikkael Sekeres, MD, who leads clinical trials, details the goals of research and what questions a patient should ask before joining a clinical trial.


Our Culture

“We create a template so we can pull back the timelines and eliminate concerns around quality and risk—because everything’s already validated in the design. Then we can work faster with no risk to quality.”

   –Jamie, Trial Delivery



About Judi

Judi speeds and improves the world's clinical trial workflows. Our cloud-based platform has 120,000 users across 171 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 certified collaboration platform.

No tags found.

Stay up-to-date with whats happening

Some sub copy covering what weekly/monthly update sand news one can expect.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.